Your session is about to expire
← Back to Search
COVID-19 Vaccine Uptake App + General Health App for COVID-19 (MoVeUP Trial)
N/A
Waitlist Available
Led By Russell J. McCulloh, MD
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 24
Awards & highlights
Summary
This trial will help determine if a mobile app can increase the number of parents who vaccinate their children against COVID-19.
Eligible Conditions
- Coronavirus Vaccines
- Telemedicine
- Vaccine Hesitancy
- Acute Lymphoblastic Leukemia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 24
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 24
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of children who complete COVID-19 vaccination, as verified in state, clinic, or participant-held records
Secondary outcome measures
Change in enrolled parent/caregiver domain scores from baseline to immediately post-intervention on the modified WHO SAGE Vaccine Hesitancy Scale adapted for the COVID-19 Vaccine
Proportion of children who receive ≥1 dose of the COVID-19 vaccination series, as verified in state, clinic, or participant-held records
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Vaccine Uptake AppExperimental Treatment1 Intervention
24-week (8 weeks with weekly push notifications; 2 monthly push notifications for 2 months [1 notification per month]; 8 weeks without) exposure to a mobile phone application (app) designed to improve parental knowledge, attitudes, and self-efficacy regarding pediatric COVID-19 vaccination. The app will address logistical and motivational barriers to pediatric COVID-19 vaccination. Participants will also receive eight weekly nudges and 1 monthly nudge for 2 months (cues to action) regarding vaccinating their child that will be sent to participants via push notifications to their mobile devices. Through branching logic, users will access content tailored to their COVID-19 vaccine knowledge and confidence gaps, locality, degree of rural-urban primary residence, primary language (English/Spanish), race/ethnicity, and child's age.
Group II: General Health AppActive Control1 Intervention
24-week (8 with weekly push notifications; 2 monthly push notifications for 2 months [1 notification per month]; 8 weeks without) exposure to a mobile phone app designed to provide information on general pediatric health and infection prevention and mitigation strategies based on recommendations from the American Academy of Pediatrics (AAP) and the Centers for Disease Control and Prevention (CDC). Eight weekly nudges and 1 monthly nudge for 2 months regarding these topics will be sent to participants via push notifications to their mobile devices.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
COVID-19 Vaccine Uptake App
2022
N/A
~730
Find a Location
Who is running the clinical trial?
University of ArkansasLead Sponsor
488 Previous Clinical Trials
149,742 Total Patients Enrolled
IDeA States Pediatric Clinical Trials NetworkLead Sponsor
5 Previous Clinical Trials
464 Total Patients Enrolled
University of MontanaOTHER
24 Previous Clinical Trials
2,847 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are able to get vaccinated for COVID-19.You are a minor as defined by the state of residency.You are a parent or caregiver.You have access to a mobile device that can store and run the study app for 24 weeksYou have received at least one dose of a COVID-19 vaccine.You have a medical condition that prevents you from receiving any COVID-19 vaccine.You have previously participated in a study for COVID-19 vaccine.You have a child who is already participating in a COVID-19 vaccine study.You cannot get the COVID-19 vaccine.You have a child or children who cannot receive any COVID-19 vaccines due to medical reasons.You have previously participated in a trial for COVID-19 vaccines or behavior.
Research Study Groups:
This trial has the following groups:- Group 1: Vaccine Uptake App
- Group 2: General Health App
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger